Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole in Advanced ER/PR Positive Uterine Leiomyosarcoma
NCT00856050Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Feb 2009
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in uterine leiomyosarcoma (uLMS), sponsored by Dana-Farber Cancer Institute. Started Feb 2009; status: completed.
02
Drugs
letrozole
03
Conditions
uterine leiomyosarcoma (uLMS)
Beyond the preview
Go deeper on NCT00856050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856050.